(Q43741466)

26 November 2017

Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against semliki forest virus infection (English)

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

22 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

22 October 2022

author name string

P. S. Morahan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1653557

22 October 2022

A. Pinto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1653557

22 October 2022

D. Stewart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1653557

22 October 2022

D. M. Murasko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1653557

22 October 2022

M. A. Brinton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1653557

22 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1653557

22 October 2022

publication date

1 March 1991

1 reference

full work available at URL

26 November 2017

https://api.elsevier.com/content/article/PII:0166354291900708?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

https://api.elsevier.com/content/article/PII:0166354291900708?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

22 October 2022

1 reference

26 November 2017

15

1 reference

26 November 2017

3

1 reference

26 November 2017

241-254

1 reference

Effect of Anti-Interferon Serum on Friend Virus Infection andFv-1-Mediated Resistance

26 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Poly I:C or IFN-alpha/beta treatment inhibits macrophage induced T cell proliferation

22 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculat

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Preparation and absorption of antiserum against mouse L cell interferon

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Effect of inapparent murine hepatitis virus infections on macrophages and host resistance

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Role of Interferon in the Antiviral State Elicited by Selected Interferon Inducers

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Interferon induction and its dependence on the primary and secondary structure of poly(inosinic acid).poly(cytidylic acid)

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Role of endogenous interferon in the anti-tumor effect of poly I·C and statolon as demonstrated by the use of anti-mouse interferon serum

22 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Production of high-titered interferon in cultures of human diploid cells

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft

22 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Antiherpes activity of the immunomodulator OK-432, a streptococcal preparation, in immunosuppressed mice

22 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death

22 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

A computer program for comparing K samples with right-censored data

22 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Activation of natural killer cells in newborn piglets by interferon induction

22 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates

22 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro

22 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome

22 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Pyran and Polyribonucleotides: Differences in Biological Activities

22 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses

22 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Comparative Therapeutic Efficacy of Recombinant Interferons-α, -β, and -γ Against Alphatogavirus, Bunyavirus, Flavivirus, and Herpesvirus Infections

22 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

The in vivo antiviral effect of CL246,738 is mediated by the independent induction of interferon-alpha and interferon-beta

22 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents

22 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

Roles of interferon and natural killer cells in the antiviral activity of 7-thia-8-oxoguanosine against Semliki Forest virus infections in mice

22 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90070-8

22 October 2022

Identifiers

1 reference

26 November 2017

1 reference